Manufacturer of Controlled Substances; Notice of Application, 38209 [2011-16294]

Download as PDF Federal Register / Vol. 76, No. 125 / Wednesday, June 29, 2011 / Notices Vernon County Vernon County Normal School, 410 S. Center Ave., Viroqua, 11000479 & Clinton St. between 6th & 9th Sts., Arkadelphia, 11000464 COLORADO Arapahoe County [FR Doc. 2011–16248 Filed 6–28–11; 8:45 am] Englewood Post Office, 3332 S. Broadway, Englewood, 11000465 BILLING CODE 4312–51–P DISTRICT OF COLUMBIA DEPARTMENT OF JUSTICE District of Columbia Drug Enforcement Administration Linnaean Hill (Boundary Increase), 3545 Williamsburg Ln., NW., Washington, 11000466 Manufacturer of Controlled Substances; Notice of Application MINNESOTA Fillmore County Bridge No. 5722, N. Section St. over Spring Valley Cr., Spring Valley, 11000467 Houston County Bridge No. 6679, MN 76 over S. Fork of Root R. (Sheldon Township), Houston, 11000468 Swift County Gethsemane Episcopal Church, 40 N. Hering St., Appleton, 11000469 Traverse County District No. 44 School, U.S. 75 (Taylor Township), Campbell, 11000470 MISSISSIPPI Lee County Baldwyn Historic District, Roughly along E. & W. Main Sts. & N. & S. 2nd Ave., Baldwyn, 11000471 Webster County Eupora Historic District, Roughly along N. Dunn St. & W. Roane Ave., Eupora, 11000472 Winston County Downtown Louisville Historic District, Bounded by Church St., W. Park St., Columbus Ave. & Mill St., Louisville, 11000473 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 14, 2011, Pharmagra Labs, Inc., 158 McLean Road, Brevard, North Carolina 28712, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Pentobarbital (2270), a basic class of controlled substance listed in schedule II. The company plans to manufacture the listed substances for analytical research and clinical trials. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 29, 2011. Dated: June 22, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Yazoo County Dated: June 22, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–16286 Filed 6–28–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Office of Justice Programs BILLING CODE 4410–09–P NEW MEXICO [OJP; BJA Docket No. 1561] McKinley County Borrego Pass Trading Post Historic District, Bldg. 1601, Co. Rd. 19, Borrego Pass, 11000475 WASHINGTON Whatcom County Lynden Department Store, 444 Front St., Lynden, 11000476 mstockstill on DSK4VPTVN1PROD with NOTICES drug product in dosage form only for distribution to its customers. The company does not import the listed controlled substance in bulk active pharmaceutical ingredient (API) form. There are no domestic sources of Nabilone in finished drug product form available in the United States. The U.S. Food and Drug Administration has approved this product for medical use in the United States. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and § 952(a), and determined that the registration of Meda Pharmaceuticals Inc. to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Meda Pharmaceuticals Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. [FR Doc. 2011–16294 Filed 6–28–11; 8:45 am] Rosedale Plantation, 5302 Bend Rd., Vaughan, 11000474 WISCONSIN Rock County Eager, Almeron, Funerary Monument and Plot, 8012 N. Cemetery Rd., Evansville, 11000477 Sauk County Rest Haven Motel, E5116 U.S. 14, Spring Green, 11000478 VerDate Mar<15>2010 38209 17:48 Jun 28, 2011 Jkt 223001 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated April 11, 2011, and published in the Federal Register on April 19, 2011, 76 FR 21915, Meda Pharmaceuticals, Inc., 705 Eldorado Street, Decatur, Illinois 62523, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Nabilone (7379), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance as a finished PO 00000 Frm 00102 Fmt 4703 Sfmt 4703 Meeting of the Department of Justice’s (DOJ’s) National Motor Vehicle Title Information System (NMVTIS) Federal Advisory Committee Bureau of Justice Assistance, Justice. ACTION: Notice of meeting. AGENCY: This is an announcement of a meeting of DOJ’s National Motor Vehicle Title Information System (NMVTIS) Federal Advisory Committee to discuss the role of the NMVTIS Federal Advisory Committee Members and various issues relating to the operation and implementation of NMVTIS. SUMMARY: E:\FR\FM\29JNN1.SGM 29JNN1

Agencies

[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Page 38209]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16294]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 14, 2011, Pharmagra 
Labs, Inc., 158 McLean Road, Brevard, North Carolina 28712, made 
application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of Pentobarbital (2270), a basic 
class of controlled substance listed in schedule II.
    The company plans to manufacture the listed substances for 
analytical research and clinical trials.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 29, 2011.

    Dated: June 22, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-16294 Filed 6-28-11; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.